Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

76.63
+0.13000.17%
Post-market: 76.750.1200+0.16%19:59 EDT
Volume:5.69M
Turnover:440.74M
Market Cap:13.91B
PE:-53.45
High:80.31
Open:77.36
Low:75.80
Close:76.50
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.87
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:31.27
PE(LYR):-54.35

Loading ...

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31

Tempus AI Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Form 4 | Tempus AI, Inc. CEO and Chairman Eric P Lefkofsky sold a total of 249,000 shares of Class A Common Stock via multiple entities

Filings Track
·
Jul 31

OpenAI Suddenly Unleashes! GPT 5.6 Series Prices Slash Up To 80%, AI Begins Self-Optimizing Code For Quantum Leap

AI Industry Frontlines
·
Jul 31

Tempus AI CEO and Chairman Eric Lefkofsky Disposes of USD 10.75 Million in Common Shares

Reuters
·
Jul 31

Tempus AI Inc Shares Fall 2% After the Bell Following Results, Outlook

THOMSON REUTERS
·
Jul 31

GUIDANCE: (TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.595B - $1.605B, vs. FactSet Est of $1.59B

MT Newswires Live
·
Jul 31

Tempus AI Q2 FY26 Swings to GAAP Profit of $5.64 Million; Revenue Rises 22% to $382.5 Million

Reuters
·
Jul 31

Tempus AI Q2 Revenue Slightly Beats Estimates

Reuters
·
Jul 31

Tempus AI Q2 Adj. EPS $(0.04) Beats $(0.14) Estimate, Sales $382.486M Beat $379.743M Estimate

Benzinga Earnings
·
Jul 31

Tempus AI Inc Q2 Income from Operations USD -75.913 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Inc Q2 Adjusted EPS USD -0.04 VS. Ibes Estimate USD -0.14

THOMSON REUTERS
·
Jul 31

Movement Alert|Tempus AI Rises 5.15% in Regular Trading, Market Positions for Earnings Recovery Ahead of Q2 Report

Market Focus
·
Jul 31

Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties

Stock Track
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

Form 144 | Tempus AI, Inc. officer and director Eric Lefkofsky proposes to sell 250,000 shares with an aggregate market value of about $10,727,500

Filings Track
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28